Imagenebio (IMA)Director bought ~$8M

~$8M

Approx. value · 268K sh @ $29.90

455K

Holds after · shares reported

Traded

Jul 25, 2025

Filed

Jul 30, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 25, 2025 · this disclosureInsiderDirector purchased ~$8M of IMA shares in the open market

What came next

1. Jul 25, 2025InsiderDirector purchased ~$2.5M of IMA shares in the open market
2. Oct 10, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 10, 2025, Jotin Marango, M.D., Ph.D., our Chief Financial Officer and principal financial officer, provided notice of his resignation, effective October 20, 2025.”
3. Oct 21, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 21, 2025, the board of directors of ImageneBio, Inc. (the “Company”) appointed Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, as the Company’s interim principal financial officer, effective immediately.”
4. Oct 23, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement
5. Nov 1, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 1, 2025, the Board of Directors (the “Board”) of ImageneBio, Inc. (the “Company”) increased the authorized size of the Board from six directors to seven directors and, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Joseph P. Slattery to the Board, effective November 1, 2025, and as the Chair of the Audit Committee of the Board, effective November 18, 2025.”
6. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Imagenebio

For Imagenebio, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMA page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Imagenebio

• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Jul 21, 2026
• SEC Form 4Jul 21, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4Dec 29, 2025
• SEC Form 4Jul 30, 2025

Everything OQRO holds on this company is on its IMA page.